Filing Details

Accession Number:
0001209191-17-044262
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-07 06:45:19
Reporting Period:
2017-07-05
Filing Date:
2017-07-07
Accepted Time:
2017-07-07 06:45:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1685071 Dova Pharmaceuticals Inc. DOVA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1568216 M. Steven Goldman C/O Dova Pharmaceuticals, Inc.
240 Leigh Farm Road, Suite 245
Durham NC 27707
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-05 42,000 $17.00 42,000 No 4 P Direct
Common Stock Acquisiton 2017-07-05 30,000 $19.25 72,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct